Lionco Pharmaceutical Group Co.,Ltd.
SSE:603669.SS
5.23 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 254.087 | 343.419 | 575.763 | 986.937 | 1,566.976 | 510.986 | 711.445 | 312.813 | 220.059 | 158.664 | 81.607 | 151.297 | 61.014 | 48.468 |
| Short Term Investments
| 31.222 | 390.59 | 389.515 | 579.125 | 180 | 355.776 | -17.376 | 503.921 | 500 | 617.548 | 0 | 20 | 0 | 0 |
| Cash and Short Term Investments
| 285.309 | 734.009 | 965.277 | 1,566.062 | 1,746.976 | 866.762 | 711.445 | 312.813 | 220.059 | 158.664 | 81.607 | 151.297 | 61.014 | 48.468 |
| Net Receivables
| 247.895 | 65.605 | 92.215 | 124.892 | 172.17 | 233.568 | 0 | 0 | 65.482 | 57.374 | 9.807 | 3.24 | 13.201 | 19.769 |
| Inventory
| 27.88 | 56.768 | 49.138 | 51.667 | 69.065 | 89.806 | 69.302 | 91.541 | 80.412 | 86.764 | 78.999 | 75.167 | 69.029 | 64.666 |
| Other Current Assets
| 25.527 | 25.151 | 25.413 | 45.665 | 48.889 | 35.927 | 0 | 515.407 | 527.144 | 641.576 | 13.858 | 39.856 | 17.251 | 13.618 |
| Total Current Assets
| 586.611 | 881.533 | 1,132.043 | 1,788.287 | 2,038.816 | 1,226.063 | 1,326.462 | 1,132.152 | 893.098 | 944.378 | 184.271 | 269.56 | 160.495 | 136.774 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 469.669 | 505.345 | 496.324 | 484.532 | 465.468 | 490.518 | 490.845 | 405.402 | 333.058 | 329.765 | 306.123 | 263.238 | 146.19 | 63.765 |
| Goodwill
| 0 | 0 | 0 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 0 | 0.457 |
| Intangible Assets
| 100.901 | 108.436 | 115.791 | 124.097 | 102.698 | 50.498 | 47.522 | 44.41 | 45.45 | 46.153 | 47.017 | 27.814 | 12.215 | 20.843 |
| Goodwill and Intangible Assets
| 100.901 | 108.436 | 115.791 | 126.127 | 104.728 | 52.528 | 49.552 | 46.44 | 47.48 | 48.183 | 49.047 | 29.844 | 12.215 | 21.301 |
| Long Term Investments
| 44.449 | -289.715 | -311.716 | -512.457 | -116.949 | -274.086 | 109.601 | 18.637 | 21.318 | 12.638 | 0 | 0 | 34.747 | 0 |
| Tax Assets
| 0 | 2.199 | 0.197 | 6.829 | 4.122 | 3.137 | 2.415 | 3.022 | 2.591 | 7.886 | 6.517 | 2.74 | 1.164 | 0.717 |
| Other Non-Current Assets
| 53.704 | 416.763 | 422.827 | 621.047 | 220.024 | 415.276 | 89.052 | 46 | 46.47 | 0.655 | 13.875 | 16.734 | 10.08 | 21.823 |
| Total Non-Current Assets
| 668.723 | 743.027 | 723.422 | 726.077 | 677.392 | 687.372 | 741.465 | 519.501 | 450.918 | 399.128 | 375.562 | 312.556 | 204.396 | 107.607 |
| Total Assets
| 1,255.334 | 1,624.56 | 1,855.465 | 2,514.364 | 2,716.209 | 1,913.436 | 2,067.927 | 1,651.653 | 1,344.015 | 1,343.507 | 559.834 | 582.116 | 364.891 | 244.381 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 109.562 | 85.497 | 66.455 | 18.95 | 55.492 | 134.3 | 141.695 | 134.313 | 87.536 | 94.398 | 126.709 | 149.042 | 27.58 | 38.332 |
| Short Term Debt
| 0 | 120.427 | 205.243 | 555.93 | 589.459 | 60.043 | 220 | 0 | 0 | 4.962 | 0 | 0 | 0 | 0 |
| Tax Payables
| 12.727 | 2.287 | 4.058 | 14.075 | 27.313 | 39.33 | 37.239 | 38.891 | 18.912 | 23.853 | 21.387 | 18.256 | 20.131 | 14.376 |
| Deferred Revenue
| 0 | 10.48 | 8.837 | 36.033 | 94.292 | 193.377 | 37.239 | 9.429 | 13.24 | 47.512 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 97.025 | 24.419 | 26.667 | 63.867 | 57.62 | 167.031 | 105.438 | 166.851 | 54.283 | -8.674 | 19.695 | 48.11 | 76.311 | 60.202 |
| Total Current Liabilities
| 219.314 | 243.11 | 302.423 | 648.849 | 731.573 | 400.705 | 504.372 | 340.055 | 160.732 | 207.09 | 167.791 | 215.408 | 124.022 | 112.91 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 262.066 | 445.185 | 413.589 | 400.68 | 497.54 | 190 | 175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 2.411 | 2.804 | 4.089 | 5.81 | 7.221 | 8.9 | 10.595 | 12.343 | 13.833 | 16.892 | 17.912 | 15.686 | 4.644 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.783 | 2.418 | 0.22 | 0.194 | 497.54 | -190 | -175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0.521 | 0 | 25.097 | 8.9 | 10.595 | 0 | 0 | 0 | 0 | 0 | 0 | 2.92 |
| Total Non-Current Liabilities
| 266.26 | 450.408 | 417.898 | 406.684 | 504.76 | 198.9 | 185.595 | 12.343 | 13.833 | 16.892 | 17.912 | 15.686 | 4.644 | 2.92 |
| Total Liabilities
| 485.574 | 693.518 | 720.321 | 1,055.533 | 1,236.334 | 599.604 | 689.968 | 352.398 | 174.566 | 223.982 | 185.703 | 231.093 | 128.667 | 115.83 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 721.244 | 721.239 | 721.238 | 721.227 | 713.44 | 509.6 | 364 | 260 | 260 | 260 | 195 | 195 | 195 | 50 |
| Retained Earnings
| -306.685 | -175.921 | -23.922 | 243.587 | 327.621 | 285.964 | 371.034 | 309.707 | 200.982 | 164.924 | 134.739 | 144.864 | 31.3 | 71.019 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 94.091 | 182.192 | 238.473 | 245.003 | 120.617 | 99.674 | 82.297 | 61.217 | 47.349 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 355.201 | 291.634 | 199.373 | 255.543 | 193.811 | 518.268 | 543.251 | 647.251 | 647.251 | 647.251 | 44.392 | 11.159 | 9.924 | 7.532 |
| Total Shareholders Equity
| 769.76 | 931.042 | 1,135.144 | 1,458.831 | 1,479.875 | 1,313.832 | 1,377.959 | 1,299.255 | 1,169.45 | 1,119.525 | 374.131 | 351.023 | 236.224 | 128.551 |
| Total Equity
| 769.76 | 931.042 | 1,135.144 | 1,458.831 | 1,479.875 | 1,313.832 | 1,377.959 | 1,299.255 | 1,169.45 | 1,119.525 | 374.131 | 351.023 | 236.224 | 128.551 |
| Total Liabilities & Shareholders Equity
| 1,255.334 | 1,624.56 | 1,855.465 | 2,514.364 | 2,716.209 | 1,913.436 | 2,067.927 | 1,651.653 | 1,344.015 | 1,343.507 | 559.834 | 582.116 | 364.891 | 244.381 |